Quality of life in pregnancy and post-partum: a study in diabetic patients
- 1.1k Downloads
We evaluated quality of life in pregnant women with diabetes followed up at Italian diabetes clinics.
A total of 245 pregnant women (30 type 1 diabetes mellitus (T1DM), 176 gestational diabetes (GDM) and 39 controls) were asked to fill in a questionnaire including the SF-36 Health Survey and the Center for Epidemiological Studies-Depression (CES-D) Scale in third trimester of pregnancy and after delivery. GDM and T1DM also completed two diabetes-specific questionnaires (Diabetes-related stress and Diabetes health distress). Quality of life scores were compared between the groups with the Mann–Whitney U-test, mean changes in scores (after delivery to 3rd trimester) were compared between groups by ANCOVA.
Regarding the SF-36 scores in the third trimester of pregnancy, T1DM and GDM women had a better Standardised Physical Component score than controls (P < 0.0001, P = 0.009, respectively). GDM and T1DM pregnant women scored significantly lower for general health perception than controls (P = 0.009 and P = 0.001, respectively). T1DM patients had lower Standardised Mental Component scores than controls (P = 0.03). Compared with the third trimester of pregnancy, the severity of depressive symptoms increased significantly after delivery in both diabetic groups, but not in controls (P < 0.0001). Scores improved in all SF-36 areas in healthy and GDM women, while they all became worse in the T1DM group.
Pregnancy is associated with a perception of poor general health in women with both T1DM and GDM. After delivery, significantly worse depressive symptoms were documented in both groups, while a generally worse physical and psychological well-being was only identified in women with T1DM. These findings have important implications for pregnancy follow-up.
KeywordsQuality of life Pregnancy Gestational diabetes Type 1 diabetes mellitus Insulin therapy
- 1.Kamysheva, E., Skouteris, H., Wetrheim, E. H., Paxton, S. J., & Milgrom, J. (2008). Examination of a multifactorial model of body-related experiences during pregnancy: The relationships among physical symptoms, sleep quality, depression, self-esteem, and negative body attitudes. Body Immage, 5(2), 152–163.CrossRefGoogle Scholar
- 11.Carpenter, M. W., & Coustan, D. R. (1982). Criteria for screening tests for gestational diabetes. Journal of Obstetrics Gynecology, 144, 768–773.Google Scholar
- 12.Metzger, B. E., Buchanan, T. A., & Coustan, D. R., et al. (2007). Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care, 30(2), S251–S260.Google Scholar
- 13.American Diabetes Association. (2004). Preconception care of women with diabetes in pregnancy. Diabetes Care, 27(Suppl 1), S76–S78.Google Scholar
- 16.Franciosi, M., Pellegrini, F., De Berardis, G., Belfiglio, M., Cavaliere, D., & Di Nardo, B., et al. (2001) The QuED Study group—quality of care and outcomes in type 2 diabetes. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients. An urgent need for better educational strategies. Diabetes Care, 24, 1870–1877.Google Scholar
- 17.De Berardis, G., Franciosi, M., Belfiglio, M., Di Nardo, B., Greenfield, S., & Kaplan, S. H., et al. (2002) Quality of care and outcomes in type 2 diabetes (QuED) study group. (2002). Erectile dysfunction and quality of life in type 2 diabetes (QuED) study group. (2002). Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. Diabetes Care, 25, 284–291.Google Scholar
- 18.Ware, J., Snow, K., Kosinski, M., & Gandek, B. (1993). SF-36 health survey: Manual and interpretation guide. Boston, MA: New England Medical Center Health Institute.Google Scholar
- 19.Ware, J. E., Kosinski, M., & Keller, S. D. (1994). SF-36 physical and mental health summary scales: A user’s manual. Boston, MA: The Health institute, New England Medical Center.Google Scholar
- 26.Samsa, G., Edelman, D., Rothman, M. L., Williams, G. R., Lipscomb, J., & Matchar, D. (1999). Determining clinically important differences in health status measures: A general approach with illustration to the health utilities index mark II. Pharmacoeconomics, 15, 141–155.PubMedCrossRefGoogle Scholar